The announcement earlier this week that Pfizer and BioNTech's SARS-CoV-2 vaccine appears effective may bode well for other, similar vaccines, the Verge reports.
"It's extremely encouraging, in my view, not only for the Pfizer vaccine, but broadly speaking for the platform," the University of Colorado's Ross Kedl tells it.